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Purpose: To determine non-radiographic risk factors differentiating atypical lipomatous 
tumors (ALTs) from lipomas.
Methods: All patients with deep-seated lipomatous tumors of the extremities treated 
from January 2000 to October 2010 were retrospectively reviewed. Factors reviewed 
included age, gender, tumor location, size, histology, local recurrence, dedifferentiation, 
and metastasis. Multivariate logistic regression models were used to evaluate the effects 
of patient characteristics on ALT status.
results: Ninety-four lipomas and 46 ALTs were included. Patients with an ALT were 
older (median: 60.5 vs. 55  years). Lipomas were evenly distributed between upper 
(48.9%) and lower extremities (51.1%), whereas ALTs predominately involved the 
lower extremities (91.3%). Median ALT size (22 cm) was greater than lipomas (10 cm), 
p < 0.0001. One lipoma (1.04%) recurred at 77 months and five ALTs (10.9%) recurred at 
an average of 39 months (19–64 months). Two ALTs originally treated with wide resection 
recurred with a dedifferentiated component and were treated with wide re-excision and 
chemotherapy. No metastases or tumor-related deaths occurred in either group at the 
time of last follow-up. Patients older than 60 years, tumors greater than 10 cm, or thigh 
location, were more likely to be diagnosed with an ALT (p < 0.05).
conclusion: Lipomatous tumors were more likely to be ALTs when the tumor was at 
least 10 cm in size, located in the thigh, or found in patients that were 60 years of age or 
older. These risk factors may be used to guide management and surveillance strategies, 
when lipomatous tumors do not display characteristic radiographic features.
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inTrODUcTiOn
Lipomatous tumors of the extremities are the most common soft tissue tumors encountered 
in clinical practice with the majority of these tumors being lipomas and atypical lipomatous 
tumors (ALTs) (1–3). ALTs account for 46% of all liposarcomas with the other sub-types being 
less frequent, which include myxoid/round cell (28%), dedifferentiated (18%), and pleomorphic 
TaBle 1 | Patient demographics and tumor location.
lipoma (n = 94) alT (n = 46) p Value
Sex 0.12
Male 40 (42.6%) 26 (56.5%)
Female 54 (57.4%) 20 (43.5%)
Age [mean, median,  
years (range)]
53.3, 55 (17–85) 58.6, 60.5 (13–84) 0.017
Location <0.0001
Lower extremity 48 (51.1%) 42 (91.3%)
Thigh 37 (39.4%) 36 (78.3%)
Leg 11 (11.7%) 6 (13%)
Upper extremity 46 (48.9%) 4 (8.7%)
Shoulder 18 (19.1%) 0 (0%)
Upper arm 16 (17.0%) 2 (4.3%)
Forearm 12 (12.8%) 2 (4.3%)
Age was compared using the Wilcoxon rank sum test. Gender and tumor location was 
compared using Chi-square and Fisher’s exact test, respectively.
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liposarcoma (8%) (4). Atypical lipomatous tumor (ALT) is 
synonymous with well-differentiated liposarcoma (5), which is 
a low grade tumor that is usually deep-seated and located in the 
buttock, thigh, and retroperitoneal areas. ALTs can be locally 
aggressive (6–8) but have very low potential to metastasize or 
dedifferentiate (5). Histologically, they are composed of variable 
amounts of mature adipose tissue interspersed with enlarged 
atypical adipocytic and stromal cells with hyperchromatic 
nuclei and prominent, thickened fibrous bands. Lipomas on 
the other hand are benign tumors composed of mature fat that 
present as solitary, slow-growing, and painless masses in the 
subcutaneous tissue; however, they may also be deep to the 
fascia or intramuscular.
Characteristic radiographic features differentiate ALTs from 
other liposarcoma sub-types, but differentiating between a lipoma 
and an ALT often presents a diagnostic dilemma. Lipomas and 
ALTs have relatively homogenous MR signal, usually equivalent 
to normal fat, and generally do not enhance after gadolinium 
administration. Some radiographic features that suggest an ALT 
rather than a lipoma are larger size, thick septae, more nodular 
appearance, less fat content, and calcification (1, 4, 6, 7, 9–12).
Diagnostic uncertainty arises when a large homogenous lipo-
matous tumor does not display radiographic features consistent 
with an ALT. When an asymptomatic lipomatous mass exhibits 
features consistent with the diagnosis of an ALT, the clinician 
may recommend excision, whereas a lipoma may be observed. 
Furthermore, length and intensity of follow-up may be affected 
by equivocal histologic diagnoses, whereby a definitive diagnosis 
of ALT cannot be established.
Here, we present a large cohort of patients that underwent 
excision of their lipoma or ALT with the purpose of determining 
non-radiographic risk factors that may help to preoperatively 
risk stratify these two entities. These risk factors will help guide 
treatment for patients presenting with equivocal radiographic 
features.
MaTerials anD MeThODs
A retrospective chart review was performed in accordance with 
the MD Anderson Institutional Review Board. The orthopedic 
oncology database was queried to identify all patients with a 
histopathologic diagnosis of lipoma or ALT of the extremities 
treated at our institution from January 1, 2000 to October 1, 2010. 
Tumors were excluded if they did not have a final pathologic 
diagnosis of lipoma or ALT, or underwent previous excision at 
an outside facility. All tumors were deep to the fascia. Factors 
reviewed included: age, gender, location of lesion, size of lesion 
based on preoperative MRI (greatest single dimension measured 
in any direction), gross pathologic size, biopsy and final histologic 
diagnosis, and history of local recurrence, dedifferentiation or 
metastasis. Length of follow-up was determined as time from 
surgery to last clinic appointment, telephone follow-up, or 
survey. One hundred sixty-six deep-seated lipomatous tumors 
were marginally excised during the study period. Twenty-six 
patients were excluded; 10 ALTs and 4 lipomas had undergone 
previous excision, 6 tumors were diagnosed as lipomas but the 
initial histopathologic diagnosis could not exclude ALT nor could 
the independent blinded review, 1 ALT had myxoid features, 2 
tumors had a final histopathologic diagnosis of fibrolipoma, 2 
were diagnosed as hibernoma, and 1 lipoma had a hemagioma 
within the lesion. The size of the lesion in the greatest dimension 
was determined by measurements obtained from the preopera-
tive MRI, ultrasound, or measurement of the gross specimen if 
no preoperative imaging was available. The location of the lesion 
was classified as upper extremity (arm and forearm), shoulder, 
or lower extremity (thigh and leg). A tumor in the hand (two 
lipomas) was classified as a forearm lesion, and a tumor in the 
ankle (one lipoma) or foot (one lipoma) was included in the leg 
classification.
Two musculoskeletal pathologists performed a blinded, inde-
pendent, randomized review of the histologic slides to obtain 
diagnoses for comparison to the original, unblinded diagnoses. 
Preoperative radiologists’ and intraoperative surgeons’ differen-
tial diagnoses were noted if included in the preoperative radiol-
ogy report or operative report, respectively. These differential 
diagnoses were compared with the final pathologic diagnosis.
Fisher’s exact test or Chi-square test was used to evaluate the 
association of age or tumor location with the diagnosis of lipoma 
or ALT. Wilcoxon rank sum test was used to determine differ-
ences in age and tumor size between patients with a lipoma or 
ALT. BLiP plots were generated for overall tumor size by lipoma 
and ALT diagnoses, as well as thigh location only. Multivariate 
logistic regression models were used to evaluate the effects of 
patient characteristics (age ≥60  years, gender, size  >  10  cm, 
or thigh location) on ALT status. p Values less than 0.05 were 
considered statistically significant. Statistical software SAS 9.1.3 
(SAS, Cary, NC, USA) and S-Plus 8.0 (TIBCO Software Inc., Palo 
Alto, CA, USA) were used for all analyses.
resUlTs
One hundred forty lipomatous tumors of the extremities met 
inclusion criteria; 94 had a final diagnosis of lipoma and 46 were 
ALTs. Patient demographics and tumor location are shown in 
Table 1. Patients with an ALT tended to be older with a median 
age of 60.5 years (range = 13–84) vs. 55 years (range = 17–85) 
TaBle 2 | Median tumor size by location (greatest dimension, cm).
lipoma (n = 94) alT (n = 46) p Value
All locations 10 (0.8–35) 22 (3.3–35) <0.0001
Lower extremity 11.8 (0.8–35) 22 (9–35) <0.0001
Thigh 12.5 (3–35) 22 (9–35) 0.0001
Leg 5 (0.8–24) 22 (18–27) 0.0057
Upper extremity 8.8 (1.8–19) 10.2 (3.3–26) 0.77
Arm 9.5 (3.5–15.5) 9.3 (3.3–15.3) 0.94
Forearm 7.5 (1.8–19) 15.5 (5–26) 0.58
Tumor Size: Longest Dimension
0 10 20 30
Lipoma
ALT
  N Min. 1st Qu. Median 3rd Qu. Max. Mean S.D.
94 0.8 6 10 14 35 11.04 6.842
  N Min. 1st Qu. Median 3rd Qu. Max. Mean S.D.
46 3.3 17 22 25 35 20.9 6.764
Distribution of Tumor Size by ALT Status
p-value<0.0001(Wilcoxon rank sum)
Tumor Size: Longest Dimension
10 20 30
Lipoma
ALT
  N Min. 1st Qu. Median 3rd Qu. Max. Mean S.D.
37 3 9 12.5 20 35 14.73 7.879
  N Min. 1st Qu. Median 3rd Qu. Max. Mean S.D.
36 9 17 22 25 35 21.54 6.218
Distribution of Tumor Size by ALT Status for Site=Lower Extremity - Thigh
p-value= 0.0001 (Wilcoxon rank sum)
Median size difference between lipomas and ALTs were compared using the Wilcoxon rank sum test. Ranges are in parentheses. BliP plots are shown comparing size distribution of all 
ALTs and lipomas (lower left) and ALTs and lipomas in the thigh (lower right).
TaBle 3 | recurrent lipoma and alT characteristics.
age 
(years)
sex site size  
(cm)
Time to 
recurrence 
(months)
Outcome
Lipoma
Patient 1 50 F Forearm 6 77 Treated with 
observation only
ALT
Patient 1 61 F Leg 21.6 43 Two recurrences 
treated with 
re-excisions
Patient 2 74 M Thigh 18 64 Re-excised. 
No recurrence at 
5 years. Unrelated 
death 10 years 
following 1° surgery
Patient 3 58 F Thigh 17 19 Treated with 
observation only
Patient 4 49 M Leg 27 33 Treated with 
observation only
Patient 5 64 F Thigh 35 36 Re-excised. 
No recurrence 
at 10 months
Time to recurrence calculated as time from primary excision until detection of 
recurrence.
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for patients diagnosed with a lipoma (p = 0.017). The location 
of lipomas and ALTs differed significantly (p < 0.0001). Lipomas 
were evenly distributed between the upper and lower extremi-
ties, 48.9 and 51.1%, respectively. Whereas, ALTs predominately 
involved the lower extremity (91.3%), 78.3% of which were 
located in the thigh.
Table  2 shows the mean tumor size by location. Overall, 
lipomas had median size of 10  cm in greatest dimension 
(range = 0.8–35 cm), while ALTs were significantly larger at 22 cm 
(range = 3.3–35 cm, p < 0.0001). Almost all ALTs were greater 
than 10 cm, 93.5 vs. 53.2% of lipomas, p < 0.0001. In the lower 
extremity, ALT size was significantly larger than lipomas; median 
size = 22 vs. 11.8 cm, respectively (p < 0.0001). ALTs tended to 
be larger in the upper extremity but this was not significant as 
there were too few ALTs available for comparison. ALTs in the 
thigh (22  cm) were significantly larger than lipomas (12.5  cm, 
p = 0.0001); however, there was significant overlap between the 
two groups (Table 2, bottom right).
Blinded, histological review confirmed the diagnosis of ALT 
in all cases of previously diagnosed ALT. On review of six cases 
initially diagnosed as lipoma, the pathologists could not entirely 
exclude ALT on purely histopathologic grounds and therefore 
these cases were excluded from analysis. None of these six cases 
recurred.
The average follow-up for lipomas was 35.4  months 
(0–139 months) and 61.3 months (1–166 months) for ALTs. Of 
the 140 tumors excised, there was 1 (1.04%) local recurrence in 
the lipoma group and 5 (10.9%) recurrences in the ALT group 
(Table 3). Recurrence of the lipoma occurred 77 months after the 
index procedure in the ipsilateral arm but the patient chose to not 
re-excise the lesion. The average time to recurrence for the five 
4Bird et al. Differentiating ALTs from Lipomas
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patients with ALTs was 39 months from excision (19–64 months). 
Two of these patients chose to observe only, one patient had two 
subsequent recurrences after re-excisions, one patient underwent 
re-excision and is without recurrence 10  months after his last 
surgery, and one patient died 60 months after his last surgery with 
no reported recurrence.
Two patients re-presented with dedifferentiated liposarcoma 
in the location of the previously excised ALT. One patient was 
a 68-year-old man who underwent marginal resection of a left 
medial thigh ALT. He was followed with repeat MR imaging for 
the next 3 years without recurrence but developed thigh swelling 
FigUre 1 | Upon initial presentation, (a) coronal and (B) axial T1 Mri showed a large deep-seated lipomatous mass within the medial thigh. The 
majority of the mass is lipomatous with some septations consistent with an ALT, which was confirmed on histology. Seven years following resection, MRI now shows 
a heterogenous lesion within the same region with very little fat signal that is dark on T1 (c) with intermediate signal on T2 (D) and enhances with gadolinium 
contrast (e). (F) Needle biopsy shows scattered pleomorphic spindle cells confirming the diagnosis of dedifferentiated liposarcoma.
7 years following his surgery. His imaging showed an enhancing 
heterogenous mass in the distal medial thigh at the same location 
of his prior resection (Figure 1). Needle biopsy was consistent 
with dedifferentiated liposarcoma. The second patient was a 
66-year-old man who initially underwent a marginal resection 
of an upper arm ALT. He re-presented 42 months following his 
surgery with a recurrent mass that was consistent with dedif-
ferentiated liposarcoma.
A multivariate logistic regression model was constructed to 
evaluate age, gender, tumor size, and thigh location as risk factors 
for having a diagnosis of ALT (Table 4). The median age for the 
5Bird et al. Differentiating ALTs from Lipomas
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DiscUssiOn
Radiographic characteristics, such as size, percent fat, thickness 
of septae, and nodularity, are features that may help distinguish 
ALTs from lipomas. Frequently, however, ALTs do not display 
these radiographic features and lipomas may also display some 
features suggestive of an ALT, leading to diagnostic uncertainty. 
Since ALTs are more apt to recur and have the potential to dedif-
ferentiate, discerning ALTs from lipomas is clinically important.
In our cohort of 140 deep-seated lipomatous tumors, we found 
that age of 60 years or older, size at least of 10 cm, and a thigh 
location were significant risk factors for an ALT diagnosis. This 
is in agreement with others who have reported that larger tumor 
size (11, 13, 14) and older age (11, 15) are risk factors associated 
with a diagnosis of ALT. Kransdorf et  al. (11) found that male 
gender was a significant risk factor for a diagnosis of ALT. Our 
results were similar, male gender reached marginally significance 
in a multivariate analysis (p = 0.059).
Histologic subtyping of the ALTs has been reported to pro-
vide  important prognostic information regarding recurrence 
rates (11). Although, histologic subtyping was not being routinely 
performed during the time period of this retrospective review, it 
is, currently being more commonly performed at our institution. 
However, this may not be the case at many institutions. Histologic 
subtyping of lipomatous tumors may not even be available at some 
institutions, nor is it feasible to perform on every case. Therefore, 
the non-radiographic risk factors identified in this study may be 
used to screen for concerning cases.
We note that our interpretations may be limited given all 
our patients were treated with surgery and we did not have 
a non-surgical cohort for comparison. Also, regular follow-up 
of these benign lipomatous tumors was highly variable dur-
ing the study period. In a number of cases, patients either 
followed-up with their local physicians or were instructed to 
return on an as needed basis. Whether or not these patients 
subsequently developed undetected recurrences or were treated 
for recurrences at another facility is largely unknown. Given 
the higher recurrence rates and potential for dedifferentiation 
in ALTs even after excision, routine surveillance with MRI is 
now recommended.
Differentiating between ALTs and lipomas may be difficult 
even after good MR imaging and routine histology. The non-
radiographic features associated with the diagnosis of ALTs were 
location deep in the thigh, size at least of 10 cm, and patient age 
of 60 years or older. These features may be used to alert clinicians 
to the higher possibility of an ALT and help clinicians determine 
appropriate management and surveillance strategies.
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